SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending due to a massive volume spike and price surge, triggering multiple trading halts, as community discussion focuses on its extremely low float and high insider ownership for a potential short squeeze. Many are comparing it to recent explosive SPACs, with speculative targets suggesting significant upside, fueled by talking points like a rumored "sex toy manufacturer" acquisition. The stock's momentum reflects its position as a key play in the current "SPAC mania" for micro-float tickers.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is rapidly trending due to a potent combination of its extremely low share float and a potential short squeeze, driving significant momentum. The recent announcement of a strategic manufacturing partnership, expected to boost production margins, further amplifies investor interest. The community is actively discussing strong buying defense and a "textbook" short squeeze play as the company continues to expand global adoption of its fingerprint drug screening technology.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings (ONDS) is trending due to recent autonomous system orders and the FCC's ban on foreign-made drones, which significantly boosts its role in the domestic market. The community is actively discussing a potential short squeeze and anticipating a significant price breakout, with many seeing dips as buying opportunities. This positions Ondas as a crucial player in the growing defense and critical infrastructure sectors for autonomous and counter-drone solutions.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending after the FDA issued a Complete Response Letter for its relacorilant hypertension indication, triggering a sharp stock decline and intense community debate. Investors are divided, with many viewing the sell-off as an overreaction given the company's existing profitable drug and other pipeline programs, while others express caution regarding potential delays and future prospects.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending following its recent FDA approval of NEREUS, the first new motion sickness treatment in over four decades, validating a significant pipeline asset. Community discussion highlights the drug's broader potential for GLP-1 induced nausea, fueling speculation of substantial upside, a potential short squeeze, and even a buyout, given the company's strong financial standing and additional upcoming regulatory catalysts.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following its CEO's strategic insights on CNBC and news of spinning off its cloud business into ChronoScale, a move seen by many as unlocking significant value and clarifying its pure-play AI data center infrastructure focus. The community is actively discussing sustained demand from hyperscalers and strong analyst confidence ahead of its upcoming earnings report, fueling bullish sentiment despite recent price volatility. This strategic realignment aims to capitalize on the booming AI infrastructure market with a clearer business model and substantial contracted revenue.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst a wave of strong bearish sentiment, largely attributed to sustained selling pressure, high short interest, and year-end tax loss harvesting. The community is actively discussing the recent FDA approval of Novo Nordisk's oral Wegovy pill, seeing a potential for partnership and a significant catalyst for HIMS's future growth in GLP-1 offerings, alongside its ongoing expansion in D2C lab testing and international markets. Despite current frustration, many long-term investors are using this dip as a buying opportunity, anticipating a strong reversal.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after rival Corcept Therapeutics received an FDA Complete Response Letter for its Cushing's syndrome drug, effectively removing a near-term competitor for Xeris's Recorlev. The community is buzzing with bullish sentiment, emphasizing Recorlev's blockbuster potential and the significant undervaluation of XERS, further supported by advancing pipeline assets like XP-8121 and robust gross margins.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending due to the FDA's acceptance and priority review of its supplemental New Drug Application for AXS-05 in Alzheimer's disease agitation, with an action date anticipated in the near future. This significant regulatory milestone, combined with growing sales of its existing CNS therapies like Auvelity, has ignited immense optimism within the community, with many anticipating substantial long-term value and discussing breakthrough potential.

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

Motorola Solutions ($MSI) is trending following strategic acquisitions in advanced communications and AI-powered video monitoring, reinforcing its leadership in mission-critical technology for public safety and enterprise security. Community sentiment reflects a strong focus on institutional accumulation, evident in large dark pool trades and technical indicators suggesting the stock is oversold, signaling potential for a reversal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best-Performing Leveraged ETF Areas of 2025

Top-leveraged ETFs of 2025 include GDXU (+795%), RKLX, MUU, HOOX, KORU, QBTX, APPX, AGQ ??? AI, gold & silver ruled Wall Street. 

<ul class="summary-bullets"><li>At the time of writing, silver was up 1% at $62.4 an ounce while futures for March 2026 deliveries jumped 2.5% to $62.56 per ounce.</li><li>Silver prices are likely to remain highly volatile as long as uncertainty over U.S. tariffs persists, a Goldman Sachs analyst told Forbes.</li><li>DXY declined 0.3% to 98.32, marking its lowest level since October 17.</li></ul>Spot silver (XAG/USD) prices jumped to a record high of $62.9 per ounce on Thursday, a day after the U.S. Federal Reserve announced the much-anticipated 25 basis point rate cut.At the time of writing, silver pared some early gains to trade 1% higher at $62.4 per ounce. Silver futures for March 2026 deliveries jumped 2.5% to $62.56 per ounce.<figure class="image"><img style="aspect-ratio:1309/859;" src="https://news.stocktwits-cdn.com/Silver_gold_png_32a5cf5d46.webp" alt="Silver, gold.png" width="1309" height="859"><figcaption>Spot Silver and Gold Prices | Source: TradingView</figcaption></figure><h2 class="st-heading-2">What’s Next For Silver?</h2>The precious metal has been on a historic run. Silver has hit fresh peaks in seven of the last 10 sessions. Daan Struyven, co-head of global commodities research at Goldman Sachs, told Forbes on Thursday that silver prices are likely to remain highly volatile as long as uncertainty over U.S. tariffs persists. Struyven also pointed to a physical squeeze in the London silver market, with inventories low as metal is being shipped to the U.S. amid tariff concerns.He said that many of the factors lifting gold, such as expectations of lower interest rates, also help silver by boosting investor demand. However, unlike gold, silver doesn’t have central bank buying as support, and it tends to be more volatile.Struyven noted that Gold ETFs are roughly 70 times smaller than the U.S. Treasury market, and silver is about nine times smaller than gold, and because of this, even modest flows into silver could drive significant gains.Meanwhile, veteran commodities expert and Head of Commodity Strategy at Saxo Bank, Ole Hansen, noted that silver could see profit-taking as risk sentiment weakened across equities.In a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/Ole_S_Hansen/status/1999015507278672209">post</a> on X, Hansen noted that the firm rejection, partly due to overbought conditions, may signal a shift in focus toward consolidation, with $59 as a major support level.<img src="https://news.stocktwits-cdn.com/Ole_Hansen_png_6e56b6f601.webp" alt="Ole Hansen.png"><h2 class="st-heading-2">Gold And Greenback</h2>Spot gold prices fell 0.2% to $4,219 an ounce, while gold futures for February 2026 deliveries climbed 0.6% to $4,249.2.Meanwhile, the dollar index (DXY) declined 0.3% to 98.32, its lowest level since October 17.<figure class="image"><img style="aspect-ratio:1299/876;" src="https://news.stocktwits-cdn.com/DXY_png_783fa1b935.webp" alt="DXY.png" width="1299" height="876"><figcaption>DXY on Dec. 10, 2025 | Source: TradingView</figcaption></figure>Read Also: <a href="https://stocktwits.com/news-articles/markets/equity/crbp-stock-surged-36-pre-market-what-did-its-obesity-treatment-drug-study-reveal/cLIxOoAREnh">CRBP Stock Surged 36% Pre-Market – What Did Its Obesity Treatment Drug Study Reveal?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Adding SilverCrest’s Las Chispas mine in Mexico is projected to bolster Coeur’s production portfolio.

Spot Silver Continues Hitting Fresh Highs – But This Analyst Warns Of Potential Consolidation

Spot silver prices jumped to a record high of $62.9 per ounce on Thursday, a day after the U.S. Federal Reserve announced the much-anticipated 25 basis point rate cut.

Equity

<ul class="summary-bullets"><li>Hansen noted that to avoid triggering the bearish setup, silver needs to stay above $48.92 mark.</li><li>Over the last six months, silver prices have surged nearly 60%.</li><li>The expert noted that on the upside, if silver pulls back slightly and then rebounds around $51 per ounce, it would signal a strong bullish signal.</li></ul>&nbsp;Driven by concerns surrounding geopolitical turmoil, safe-haven assets have been drawing investor interest, as reflected in the sharp rise in gold and silver prices. Over the last six months, silver prices have surged nearly 60%, including a 10% jump this week.However, the spot silver chart suggests a double-top pattern, a formation that often precedes a downturn.In a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/Ole_S_Hansen/status/1989307599087432133">post on X</a> on Friday, veteran commodities expert and Head of Commodity Strategy for Saxo Bank, Ole Hansen, flagged key levels to watch out for.&nbsp;Hansen stated that to avoid triggering that bearish setup, silver needs to stay above $48.92 per ounce during this equity-driven risk-off phase. Ideally, prices should remain above the $ 50-per-ounce mark, Hansen added.<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/Ole_S_Hansen/status/1989307599087432133"><img src="https://news.stocktwits-cdn.com/Ole_Hansen_png_b49f48973b.webp" alt="Ole Hansen.png"></a>At the time of writing, spot silver (<a href="https://stocktwits.com/symbol/XAGUSD">XAG/USD</a>) was down 3% at $50.70 per ounce.The expert noted that on the upside, if silver pulls back slightly and then rebounds around $51 per ounce, it would signal a strong bullish signal.<h2 class="st-heading-2">Silver Leads Commodities Rally</h2>In a Saxo Bank report on Friday, Hansen noted the Bloomberg Commodity Index is heading for its best week since June and is up more than 15% this year, with nearly every major commodity category contributing to the rally, including precious metals, energy, grains, and industrial metals.&nbsp;Silver, natural gas, sugar, gold, and soybeans are among the top performers. This broad strength stands out against the weakness in tech stocks and crypto, he wrote. Silver prices are set to rise for the seventh consecutive month and for the ninth time in the past eleven months. On Thursday, silver prices jumped to an all-time high of $54.42 per ounce.Silver has significantly outperformed gold over the past six months, with 27.6% gains – more than double those of gold (<a href="https://stocktwits.com/symbol/XAUUSD">XAU/USD</a>).For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, one-ounce American Silver Eagle bullion coin is placed among one-ounce silver bullion coins

Is Silver's Recent Double-Top Formation Concerning? Ole Hansen Talks About Some Important Levels To Watch Out For

Over the last six months, silver prices have surged nearly 60%, including a 10% jump this week, but technical charts indicate potential resistance

Silver Shines Brighter Than Gold: ETFs in Focus 

Silver hovers around $40, marking its strongest level since 2011 (per tradingeconomics), with ETFs like SLV up about 37% this year, outpacing gold-backed GLD.



Silver prices continued to retreat on Friday, falling more than 1% in morning trade, pressured by a firm U.S. dollar. Silver was currently trading at $35.91, 3.7% below its 13-year high of $37.31, seen earlier this month.&nbsp;Although the&nbsp;<a href="https://stocktwits.com/symbol/DXY">U.S. Dollar Index (DXY)</a> was flat early Friday, it is up nearly 0.5% for the week. Silver is down 1.1% over the same period. The&nbsp;<a href="https://stocktwits.com/symbol/SLV">iShares Silver Trust (SLV)</a> was down 1.3% Friday morning, and&nbsp;<a href="https://stocktwits.com/symbol/AGQ">ProShares UltraShort Silver (AGQ)</a> dipped 2.8%.&nbsp;The recent rally in&nbsp;<a href="https://stocktwits.com/symbol/XAGUSD">silver prices</a> to a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/silver-prices-hit-13-year-high-but-still-trail-gold-s-2025-rally/chkDpl4RbxI">13-year high</a> was driven by both geopolitical tensions, including the ongoing conflict between Iran and Israel in the Middle East, and resilient demand from industrial sectors.Unlike gold, which is primarily used as a store of value, most of the grey metal’s demand comes from manufacturers.&nbsp;Industrial demand, especially from electronics, cutlery, and solar panel production, has remained steady, said Michael Widmer, Bank of America’s head of metals research, as&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/finance/commodities-futures/silver-prices-surge-8afe2e4b">told</a> to The Wall Street Journal (WSJ).The iShares Silver Trust, a popular ETF among retail investors that holds physical silver, has added nearly 11 million ounces to its reserves this year to meet rising demand, according to fund documents cited by the publication.&nbsp;However, JPMorgan’s head of metals research, Greg Shearer, warned that demand from solar manufacturers, particularly in China, may have been pulled forward due to anticipated trade restrictions and shifting U.S. energy policy under President Donald Trump. There is a risk of a slowdown in the second half of the year, he told The WSJ.Prices of silver have gained more than 24% this year and 20% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/coinbase-becomes-first-us-company-to-secure-mi-ca-license-in-luxembourg/chlxZNuRRPr">Coinbase Becomes First US Company To Secure MiCA License In Luxembourg, Ditches Ireland As EU Crypto Hub</a>

Representative image of solar panels, which use silver in their photovoltaic (PV) cells, due its excellent electrical conductivity. (Photo by Westend61/Getty Images)

Silver Prices Slip Over 3% From Recent 13-Year High, But Analysts Say Solar And Industrial Demand Still Support Bull Case

JPMorgan’s Greg Shearer told The Wall Street Journal that solar-related silver demand may slow later this year after being pulled forward ahead of expected trade and energy policy changes in the U.S.

UBS refreshes its silver prices outlook for 2025

Investing.com -- UBS said it expects silver prices to climb as high as $40 per ounce in the coming months, driven by investor appetite for U.S. dollar alternatives, continued ETF inflows, and a weaker greenback.

AGQ
ProShares Ultra Silver

Feed

News

Sentiment

Fundamentals

Info

Latest AGQ News

AGQProShares Ultra Silver